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ABSTRACT 
 
Drugs and surgery can interfere with the biodistribution of radiopharmaceuticals and data about the effect of 
splenectomy on the metabolism of phytate-Tc-99m are scarce. This study aimed at evaluating the interference of 
splenectomy on phytate-Tc-99m biodistribution and liver function in rats. The SP group rats (n=6) underwent 
splenectomy. In group C (control) the animals were not operated on. After 15 days, all rats were injected with 
0.1mL of Tc-99m-phytate via orbital plexus (0.66MBq). After 30 minutes, liver samples were harvested, weighed 
and the percentage of radioactivity per gram (%ATI/g) was determined by a Wizard Perkin-Elme gama counter.  
The ATI%/g in splenectomized rats (0.99±0.02) was significantly higher than in controls (0.4±0.02), (p=0.034). 
ALT, AST and HDL were significantly lower in SP rats (p= 0.001) and leukocytosis was observed in SP rats. In 
conclusion, splenectomy in rats changed the hepatic biodistribution of Tc-99m-phytate and liver enzimatic activity. 
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INTRODUCTION 
 
The spleen is the largest lymphoid organ in the 
body. Its functions are many, but they are 
generally related to 1 of 4 categories: filtration, 
immunologic, reservoir, and hematopoietic. Many 
of the spleen’s immunologic functions, therefore, 
are common to other immunologic organs. For 
example, the spleen is efficient at removing non-
opsonized bacteria, mostly encapsulated organisms 
(Müftüoğlu et al., 2000). Splenectomy is 
frequently performed for a multitude of reasons, 
including trauma and various pathologic 
processes. Blunt abdominal trauma remains the 
most common indication for splenectomy, but 
patients with a variety of hematologic disorders 
also benefit from this procedure. Loss of the 
spleen, however, leads to a lifelong higher risk of 
sepsis and severe infection (Bader-Meunier et al., 
2001, Waghorn et al., 1997) and may be associated 
with an increased rate of thromboembolic 
complications, enhanced arteriosclerosis, and late 
coronary heart disease (Schilling, 1997). It has 
been reported that splenectomy might promote 
hepatic regeneration, prevent liver fibrosis 
(Akahoshi et al., 2002, Murata et al., 2001), reduce 
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serum bilirubin concentration and improve liver 
function (Shimada et al., 2000, Lin et al., 1999).  
However, considering the relationship between the 
spleen and liver physiology, nuclear medicine may 
have an important role in studying the diagnosis 
and physiology of the liver after splenectomy.  
Since its introduction a number of years ago, Tc-
99m-phytate colloid has been used as an imaging 
agent for the liver and spleen (Huet et al., 1980). 
Subjective assessment of parameters such as liver 
dimension, colloid shift, and radiopharmaceutical 
uptake in the bone marrow have been used for 
both liver disease diagnosis and evaluation of its 
progression. Subjective assessment of radiocolloid 
distribution has been shown to be unreliable, and 
quantitative techniques have been used to evaluate 
liver function (Jago et al., 1987). The distribution 
of radiocolloid uptake in the liver and bone 
marrow has been shown to correlate well with the 
severity of chronic liver disease, the severity of 
histologic fibrosis, prognosis, and hepatic function 
(Hoefs et al., 1997).  Thus, quantitation of liver 
uptake of 99mTc-phytate colloid provides a 
practical index of hepatic function, by using planar 
and single photon emission computed tomography 
(SPECT) techniques (Strauss et al., 1984). The 
ability to quantitate individual organ volumes and 
radiopharmaceutical concentrations with SPECT 
(Front et al., 1987, Iosilevsky et al., 1989) 
stimulates the use of Tc-99m-phytate colloid 
scintigraphy of the liver as a quantitative test of 
hepatic function. Radiopharceutical biodistribution 
may provide important information about its 
uptake to some target organs but post -surgery data 
are scarce (Chacon et al., 2007, Araújo-Filho et al., 
2007). 
This study aimed at evaluating if splenectomy 
interferes with liver function and the 
biodistribution of Tc-99m-fytate in the liver of 
Wistar rats.  
 
 
MATERIAL AND METHODS 
 
Animals 
Male Wistar rats weighing 274±21g were obtained 
from the Center for Health Sciences vivarium, 
Universidade Federal do Rio Grande do Norte 
(UFRN), Brazil. The animals were housed in 
polypropylene cages and fed standard rat chow 
and water ad libitum. Prior to surgery, the rats 
were fasted overnight in separate cages. After 7 
days of acclimatization, they were allocated to two 
groups of 6 animals each. The groups were 
denominated splenectomy (SP) and control (C). 
The protocol for this study was approved by the 
Institutional Animal Care Committee, and the 
research was performed in accordance with 
Brazilian College of Animal Experimentation 
guidelines  
 
Surgical procedure for splenectomy 
The rats were anesthetized with ketamine 50 
mg/kg IM and thiopental (20 mg/kg IP), shaved 
and placed on an operating board and secured with 
tape. Midline laparotomy (3cm) was performed 
after skin sterilization with 70% ethanol. The 
animals were then covered with a small sterile 
drape with a 6cm circular opening. In group SP 
(n=6) the spleen was identified and resected after 
ligature of the splenic vessels with vicryl 5-0 
(Ethicon, São Paulo, Brazil). The peritoneal cavity 
was irrigated with warm (37 °C) normal saline. 
The laparotomy wound was closed with 4-0 nylon 
in layers and individual rats were placed in 
separate cages. They were allowed water ad 
libitum and rat chow 24 h postoperatively. The C 
rats (n=6) were neither anesthetized nor operated 
on. Hydration was done with normal saline (10 
mL/100g weight) injected subcutaneously in the 
back of the rats for the first two postoperative 
days. Postoperative pain was treated with 
tenoxicam (Roche Pharm., Brazil); 10 mg/kg was 
given i.m. to the rats once a day for three days. 
 
Body weight and clinical observation 
Body weight was monitored weekly throughout 
the entire 15-day experimental period. Activity, 
mucosa and skin color were observed daily. 
 
Radioactivity count 
Sodium pertechnetate (Na99mTcO4) was obtained 
by elution of a 99Mo/99mTc generator (Instituto de 
Pesquisas Energéticas e Nucleares, Comissão 
Nacional de Energia Nuclear, Brazil), and 99mTc-
phytate was prepared. On the 15th day all the 
animals were anesthetized again, and injected with 
0.lmL of 99mTc-phytate in the orbital plexus, 
corresponding to radioactivity of 0.66MBq. After 
30 minutes, blood was collected by cardiac 
puncture for dosages and the animals were killed 
by lethal dose of anesthetic. Samples of the liver 
were harvested. The samples were washed in 0.9% 
saline, weighed on a high-precision digital scale 
(Bel-Mark 160-II Itália) and subjected to 
radioactivity detection using a 1470 WizardTM 
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Gamma Counter - Perkin-Elmer, Finland, with 
automatic correction of radiation decline. The 
percentage of radioactivity/g (%ATI/g) of each 
organ was calculated by dividing the activity/g of 
the hepatic tissue by the total activity administered 
to each animal.  
 
Laboratory analysis 
A blood sample was used for hematological 
analysis of white blood cells (Abbot Cell Dyn 
3500 automatic analyzer) and for the serum 
measure of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST) and lactic 
desydrogenase activity, we used the Konelab 60i 
spectrophotometer (assay kit from Weiner, São 
Paulo, Brazil).  
 
Statistics 
The data were expressed as mean±standard 
deviation (SD). The groups were compared using 
ANOVA and the post-hoc Student test, 
considering a significance level of p<0.05. 
 
 
RESULTS 
 
Postsplenectomy symptoms such as hematuria, 
pale mucosa and lethargy were observed in 3 
animals but not in control rats. We observed no 
significant body weight loss in splenectomized 
rats, compared to controls. Radioactivity per gram 
of liver tissue ((%ATI/g) was increased by prior 
splenectomy in the SP group rats (0.99±0.2), when 
compared to the control (C) group (0.4±0.2). The 
difference between the two groups was significant 
(p=0.034; Table 1). 
To examine the effects of prior splenectomy on 
liver function, we assessed the levels of ALT, AST 
and LDH activity, as a marker of liver injury, at 15 
days postsplenectomy (Table 1). In 
splenectomized rats, ALT, AST and LDH values 
were markedly reduced, compared with the control 
group rats (p=0.001; Table 1). In addition, 
splenectomy resulted in increased white blood cell 
counts in the SP rats (13.8± 2.7 k/µL), when 
compared to the C rats (2.5±0.9 k/µL; Table 1). 
 
Table 1 - Results of percentage of radioactivity per gram (%ATI/g) of liver, hepatic enzyme activity and WBC 
count. 
Examinations Splenectomy Control p(1) 
Liver (%ATI/g) 0.99 ± 0.2b 0.4 ± 0.2 0.034 
ALT (U/L) 114.6 ± 10.9 157.5 ± 13.2 0.001 
AST (U/L) 51.6 ± 7.8 62.0 ± 2.5 0.041 
LDH (mg/dL) 8.2 ± 2.4 16.1 ± 1.1 0.001 
WBC (k/µL) 13.8±2.7 2.5± 0.9 <0.001 
Mean ± standard deviation; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDH, lactic dehydrogenase; p-
value from t test for independent samples; WBC, white blood cells. 
 
 
DISCUSSION 
 
Based on current knowledge, there is no doubt that 
the spleen is a lymphoid organ. Filtration, 
immunology, reservoir, and hematopoiesis are 
such important functions, that partial splenectomy 
or the preservation of the organ by suture is 
indicated in cases of traumatic injuries (Resende 
and Petroianu, 2003). Various complications and 
beneficial effects of the operation are described in 
postoperative splenectomy (Cadili and Gara., 
2008). Splenectomy might promote hepatic 
regeneration to a certain extent and prevent liver 
fibrosis (Murata et al., 2001, Chen et al., 1998).  
In this study we demonstrated that in 
splenectomized rats the biodistribution of 99mTc-
phytate to the liver was higher than in controls, 
suggesting that the operation favored the hepatic 
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uptake of the radiopharmaceutical. This result 
coincided with the improvement in liver function, 
confirmed by the better alanine aminotransferase, 
aspartate aminotransferase and lactic 
dehydrogenase activities in splenectomized rats, 
compared with controls.  In some studies 
splenectomy promoted hepatic regeneration 
(Akahoshi et al., 2002, Murata et al., 2001), 
prevented liver fibrosis (Chen et al., 1998), 
reduced serum bilirubin concentration and, 
consequently, reflected the effect of splenectomy 
on reducing the burden of hepatocyte bilirubin 
metabolism, improving liver function (Shimada et 
al, 2000, Lin et al., 1999). 
Tomikawa et al (1996) reported that splenectomy 
increased hepatocyte growth factor (HGF) 
activities in plasma, suggesting that the spleen 
played an inhibitory role in hepatic regeneration. 
HGF, first identified as the most potent mitogen 
for primary hepatocytes, not only stimulates 
hepatic regeneration but also accelerates liver 
function. Moreover, the fact that a large amount of 
splenic tissue connects to liver tissue through the 
portal vein system, suggests the existence of a 
humoral factor originating in the spleen, which 
thus inhibits hepatic regeneration and promotes 
liver fibrosis. In rats submitted do hepatic 
ischemia/reperfusion, prior splenectomy 
ameliorated acute multiple organ damage (Jiang et 
al., 2007). These findings, associated to the 
favorable serum activity of ALT, AST and LDH in 
our splenectomized rats, partially explain the high 
hepatic biodistribution of 99mTc-phytate in the 
operated animals. 
The postsplenectomy diagnosis of sepsis based on 
elevated white blood cell (WBC) counts is 
confounded by the fact that leukocytosis is 
considered a physiologic response to splenectomy 
(Horowitz et al., 1992).  Some reports suggest that 
postsplenectomy WBC counts in patients with 
sepsis are greater and more persistent than the 
WBC in patients without sepsis (Weng et al., 
2005, Rutherford et al., 1994).  
In this study we were not able to diagnose sepsis 
in the splenectomized rats. Nevertheless, all the 
operated animals had leukocytosis (WBC ranging 
from 11 to 18 k/µL) in the 15th postoperative day. 
It has been reported that by the fifth day following 
post-traumatic splenectomy, the WBC count may 
help the physician to confirm the development of 
sepsis and the need for treatment. If the WBC is 
greater than 15x103/µL on that day, the physician 
should seriously consider treatment by empiric 
antibiotics and further diagnostic follow-up to 
prevent the untoward sequelae of postsplenectomy 
sepsis (Toutouzas et al., 2002). In conclusion, 
splenectomy improved the liver uptake of Tc-99m-
phyate in rats, coinciding with changes in hepatic 
enzymatic activity. 
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RESUMO 
 
O radiofármaco fitato-Tc-99m é usado no 
diagnóstico através de exames de imagem, na 
dependência de sua biodistribuição. O objetivo do 
trabalho foi avaliar efeito da esplenectomia na 
biodistribuição do fitato-Tc-99m e função hepática 
em ratos Wistar. Sob anestesia e técnica asséptica, 
os animais do grupo SP (n=6) foram 
esplenectomizados. Grupo C(controle; n=6) não 
operado. Após 15 dias, injeção de 0,1ml de fitato-
Tc-99m via plexo orbital (0,66MBq). Após 30 
minutos, retiradas biópsias hepáticas para 
determinação do percentual de 
radioatividade/grama (% ATI/g), usando-se 
contador gama WizardPerkin-Elmer. Realizada 
dosagem de ALT, AST e HDL, e leucometria. 
Estatística pelo teste t, significância 0,05. O 
%ATI/g nos ratos esplenectomizados foi 0,99 ± 
0,2 e nos controles 0,40 ± 0,2 (p=0,034). ALT, 
AST e HDL tiveram dosagens significativamente 
menores nos esplenectomizados (p=0,01), com 
leucocitose, comparando com controles. Em 
conclusão, em ratos a esplenectomia provocou 
alteração na captação de fitato-Tc-99m pelo 
fígado, coincidindo com alteração da função 
hepática.  
Palavras-Chave: esplenectomia, fitato de sódio, 
biodistribuição, fígado 
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